OI
DXCM icon

Oakbrook Investments’s DexCom DXCM Stock Holding History

Oakbrook Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,700
Closed -$735K – 595
2019
Q3 		$735K Buy
19,700
+10,100
+105% +$392K 0.05% 302
2019
Q2 		$360K Sell
9,600
-7,100
-43% -$223K 0.02% 453
2019
Q1 		$497K Hold
16,700
– – 0.03% 399
2018
Q4 		$500K Buy
+16,700
New +$530K 0.03% 368

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Oakbrook Investments's DXCM Position: Q4 2019 in Review

Oakbrook Investments sold out of DexCom (DXCM) in Q4 2019, closing a stake of 19,700 shares — an estimated $735K sold.

Oakbrook Investments first reported a position in DXCM in Q4 2018 and held it in 4 quarters. The position peaked at $735K in Q3 2019. 509 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

  • Oakbrook Investments reported no remaining DexCom position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 19,700 DexCom shares in Q4 2019, an estimated $735K.
  • Oakbrook Investments first reported a position in DexCom in Q4 2018 and held it in 4 quarters.
  • Oakbrook Investments's DexCom position peaked at $735K in Q3 2019.
  • 509 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.